Is the worst over for Slater & Gordon Limited shares?

Slater & Gordon Limited (ASX:SGH) is trading more than 4% lower, after CEO Andrew Grech responded to media speculation that McGrathNicol had been appointed to review the law firm's accounts.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

What: Last night, Slater & Gordon Limited (ASX: SGH) CEO Andrew Grech responded to media speculation that the embattled law firm's bankers had appointed investigative accountants to review its accounts.

So what: In a statement to the ASX shortly before 8 pm on Thursday, Mr Grech confirmed the appointment of the banking syndicate's accountant, McGrathNicol.

"In our FY16 Financial Update on 17 December 2015, we informed the market that Slater and Gordon has more than A$100 million headroom within its banking facilities, that this headroom is expected to increase as the financial year progresses, and that we had commenced a review of the Company's forecasts by Group CFO Bryce Houghton and independent advisors appointed by the Board," Mr Grech said.

Last month, Slater & Gordon retracted its earlier profit forecasts following continued media scrutiny.

"As part of that review process, we agreed that our banking syndicate would appoint their own advisers who will work alongside those appointed by the Board," Mr Grech added.

Westpac Banking Corp (ASX: WBC) and National Australia Bank Ltd. (ASX: NAB) are part of Slater & Gordon's banking syndicate.

Now what: Slater & Gordon was one of the ASX's biggest losers throughout 2015, as speculation over its financial health, reporting and an ill-timed acquisition in the UK resulted in shares falling from over $8 to below 70 cents today.

Although its share price may prove to be dirt cheap after another 4% fall this morning, it would take a brave investor to buy Slater & Gordon shares today.

Motley Fool writer/analyst Owen Raszkiewicz owns shares of Slater & Gordon.  Owen welcomes your feedback on Google plus (see below), LinkedIn or you can follow him on Twitter @ASXinvest. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »